Progen Pharmaceuticals Limited (PGL) - Financial and Strategic SWOT Analysis Review

Progen Pharmaceuticals Limited (PGL) - Financial and Strategic SWOT Analysis Review

Summary

Progen Pharmaceuticals Limited (Progen Pharmaceuticals) is a biotechnology company. The company engaged in clinical stage oncology drug development, discovery, research, and development of biopharmaceutical therapeutics for the treatment of human diseases. It focuses on the development of anti-angiogenesis and anti-metastatic oncology product pipeline, which includes the compounds muparfostat PI-88 and PG545. This dual mechanism therapeutic approach focuses on controlling both tumour growth and spread. The company has initiated a Phase I clinical trial for PG545 in advanced cancer patients.

Progen Pharmaceuticals Limited Key Recent Developments

Jun 16, 2011 Progen Announces Board And Senior Management Changes
Mar 30, 2011 Progen Enters Diabetes Collaboration With Australian National University

This comprehensive SWOT profile of Progen Pharmaceuticals Limited provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Key manufacturing facilities – A list of key manufacturing facilities of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Note: Some sections may be missing if data is unavailable for the company.

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Key Words

Progen Pharmaceuticals Limited, SWOT analysis, SWOT, Strengths, Weaknesses, Opportunities, Threats, Corporate Strategy, Key Ratios, Share Data, Performance, Financial Performance, Overview, Business Description, Major Product, Brands, History, Key Employees, Key Operational Heads, Strategy, Key Competitors, Company Statement, Capital Market Ratios, Financial Ratios, Annual Ratios, Interim Ratios, Ratio Charts SHOW LESS READ MORE >

List of Tables
List of Figures
Section 1 - About the Company
Progen Pharmaceuticals Limited - Key Facts
Progen Pharmaceuticals Limited - Key Employees
Progen Pharmaceuticals Limited - Key Employee Biographies
Progen Pharmaceuticals Limited - Major Products and Services
Progen Pharmaceuticals Limited - Pharmaceutical Pipeline Products Data
Progen Pharmaceuticals Limited, Pipeline Products by Therapy Area
Progen Pharmaceuticals Limited, Pipeline Products by Development Phase
Progen Pharmaceuticals Limited - History
Progen Pharmaceuticals Limited - Company Statement
Progen Pharmaceuticals Limited - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Section 2 – Company Analysis
Progen Pharmaceuticals Limited - Business Description
Progen Pharmaceuticals Limited - SWOT Analysis
SWOT Analysis - Overview
Progen Pharmaceuticals Limited - Strengths
Strength - Proprietary Technology Platforms
Strength - Strong Efficiency Ratios
Strength - Innovation - Key to Success
Progen Pharmaceuticals Limited - Weaknesses
Weakness - History of Operating Losses
Weakness - Limited Liquidity
Progen Pharmaceuticals Limited - Opportunities
Opportunity - Establishment of Epi Pharmaceuticals Inc.
Opportunity - Strategic Collaborations
Opportunity - Biotech Focus
Progen Pharmaceuticals Limited - Threats
Threat - Risk of Product Obsolescence
Threat - Competitive Landscape
Threat - Regulatory Pressures
Progen Pharmaceuticals Limited - Key Competitors
Section 3 – Company Financial Ratios
Financial Ratios - Capital Market Ratios
Financial Ratios - Annual Ratios
Performance Chart
Financial Performance
Financial Ratios - Interim Ratios
Financial Ratios - Ratio Charts
Section 4 – Company’s Lifesciences Financial Deals and Alliances
Progen Pharmaceuticals Limited, Pharmaceuticals & Healthcare, Deals By Year, 2006 to YTD 2012
Progen Pharmaceuticals Limited, Pharmaceuticals & Healthcare, Deals By Type, 2006 to YTD 2012
Progen Pharmaceuticals Limited, Recent Deals Summary
Section 5 – Company’s Recent Developments
Progen Pharmaceuticals Limited, Recent Developments
Jun 16, 2011: Progen Announces Board And Senior Management Changes
Mar 30, 2011: Progen Enters Diabetes Collaboration With Australian National University
Section 6 – Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

List of Tables
Progen Pharmaceuticals Limited, Key Facts
Progen Pharmaceuticals Limited, Key Employees
Progen Pharmaceuticals Limited, Key Employee Biographies
Progen Pharmaceuticals Limited, Major Products and Services
Progen Pharmaceuticals Limited, Number of Pipeline Products by Therapy Area
Progen Pharmaceuticals Limited, Number of Pipeline Products by Development Stage
Progen Pharmaceuticals Limited, Pipeline Products By Therapy Area and Development Phase
Progen Pharmaceuticals Limited, History
Progen Pharmaceuticals Limited, Subsidiaries
Progen Pharmaceuticals Limited, Key Competitors
Progen Pharmaceuticals Limited, Ratios based on current share price
Progen Pharmaceuticals Limited, Annual Ratios
Progen Pharmaceuticals Limited, Interim Ratios
Progen Pharmaceuticals Limited, Pharmaceuticals & Healthcare, Deals By Year, 2006 to YTD 2012
Progen Pharmaceuticals Limited, Pharmaceuticals & Healthcare, Deals By Type, 2006 to YTD 2012
Progen Pharmaceuticals Limited, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

List of Figures
Progen Pharmaceuticals Limited, Pipeline Products by Therapy Area
Progen Pharmaceuticals Limited, Pipeline Products by Development Phase
Progen Pharmaceuticals Limited, Performance Chart (2007 - 2011)
Progen Pharmaceuticals Limited, Ratio Charts
Progen Pharmaceuticals Limited, Pharmaceuticals & Healthcare, Deals By Year, 2006 to YTD 2012
Progen Pharmaceuticals Limited, Pharmaceuticals & Healthcare, Deals by Type, 2006 to YTD 2012

Genentech, Inc.
Novogen Limited
Rockeby Biomed Limited
Access Pharmaceuticals, Inc.
ChemGenex Pharmaceuticals Limited